- Home
- RIGL vs NIPG Comparison
RIGL vs NIPG Comparison
Compare RIGL & NIPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RIGL
- NIPG
- Stock Information
- Founded
- RIGL 1996
- NIPG 2014
- Country
- RIGL United States
- NIPG Sweden
- Employees
- RIGL N/A
- NIPG N/A
- Industry
- RIGL Biotechnology: Pharmaceutical Preparations
- NIPG
- Sector
- RIGL Health Care
- NIPG
- Exchange
- RIGL Nasdaq
- NIPG NYSE
- Market Cap
- RIGL 486.4M
- NIPG 396.5M
- IPO Year
- RIGL 2000
- NIPG 2024
- Fundamental
- Price
- RIGL $21.81
- NIPG $6.80
- Analyst Decision
- RIGL Buy
- NIPG Strong Buy
- Analyst Count
- RIGL 5
- NIPG 1
- Target Price
- RIGL $34.80
- NIPG $12.00
- AVG Volume (30 Days)
- RIGL 347.9K
- NIPG 63.0K
- Earning Date
- RIGL 03-04-2025
- NIPG 02-15-2025
- Dividend Yield
- RIGL N/A
- NIPG N/A
- EPS Growth
- RIGL N/A
- NIPG N/A
- EPS
- RIGL 0.22
- NIPG N/A
- Revenue
- RIGL $157,374,000.00
- NIPG $84,449,477.00
- Revenue This Year
- RIGL $51.34
- NIPG N/A
- Revenue Next Year
- RIGL $15.75
- NIPG N/A
- P/E Ratio
- RIGL $98.50
- NIPG N/A
- Revenue Growth
- RIGL 21.65
- NIPG 6.07
- 52 Week Low
- RIGL $7.48
- NIPG $5.40
- 52 Week High
- RIGL $29.82
- NIPG $17.76
- Technical
- Relative Strength Index (RSI)
- RIGL 64.53
- NIPG N/A
- Support Level
- RIGL $17.28
- NIPG N/A
- Resistance Level
- RIGL $18.25
- NIPG N/A
- Average True Range (ATR)
- RIGL 1.37
- NIPG 0.00
- MACD
- RIGL 0.65
- NIPG 0.00
- Stochastic Oscillator
- RIGL 99.68
- NIPG 0.00
About RIGL Rigel Pharmaceuticals Inc.
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's lead drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.
About NIPG NIP GROUP INC SPON ADS EACH REPR 2 CL A ORD SHS
NIP Group Inc is a esports organization with operations across Asia, Europe and South America. It operate two esports brands: Ninjas in Pyjamas and eStar Gaming. Ninjas in Pyjamas, is a PC or console esports brand. eStar Gaming, is a mobile esports brand. The company has two reportable segments, including PRC and other entities, and Ninjas in Pyjamas. Key revenue is generated from PRC and other entities.